1. Market Research
  2. > Healthcare Market Trends
  3. > Malaysia Pharmaceuticals and Healthcare Report 2016

Malaysia Pharmaceuticals and Healthcare Report 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 105 pages

Includes 3 FREE quarterly updates

BMI View: Although the 2016 health budget assigned to the ministry of health comes in lower than in 2015,we believe the government remains committed to expanding healthcare access The construction of morehealth clinics under the 1Malaysia brand and the increased number of zero-rated drugs under the Goodsand Service Tax will help make medicines and services more affordable for low-income patients However,the fall of the ringgit may have a negative impact drug costs in the coming months as well as hospitalisationfees in the longer term

Headline Expenditure Projections

- Pharmaceuticals: MYR722bn (USD221bn) in 2014 to MYR788bn (USD197bn) in 2015; +92% inlocal currency and -107% in US dollar terms Forecast unchanged from last quarter

- Healthcare: MYR4262bn (USD1302bn) in 2014 to MYR4585bn (USD1146bn) in 2015; +76% inlocal currency and -120% in US dollar terms Forecast unchanged from last quarter

Table Of Contents

Malaysia Pharmaceuticals and Healthcare Report 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Malaysia 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Malaysia 2011-2019) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2011-2019) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2011-2019) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Malaysia 2011-2019) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Malaysia 2011-2019) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Malaysia 2011-2019) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Malaysia 2011-2019) 27
OTC Medicine Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Malaysia 2011-2019) 30
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (Malaysia 2013-2019) 33
Table: Pharmaceutical Trade Data And Forecasts local currency (Malaysia 2013-2019) 33
Industry Risk/Reward Index 34
Asia Pacific Risk/Reward Index 34
Malaysia Risk/Reward Index 41
Rewards 41
Risks 41
Market Overview 43
Epidemiology 43
Healthcare Sector 45
Table: 2011 Entry Point Projects Summary 47
Table: Healthcare Resources (Malaysia 2009-2014) 48
Table: Healthcare Personnel (Malaysia 2009-2014) 48
Table: Healthcare Activity (Malaysia 2009-2014) 49
Healthcare Insurance 49
Table: Main Features Of 1Care 49
Healthcare Funding 51
Healthcare Sector Developments 52
Table: Public Sector And Private Sector Healthcare Developments 52
Medical Tourism 53
Research and Development 54
Clinical Trials 56
Regulatory Review 58
Regulatory Regime 58
Table: Drug Applications by Type, 2002-2010 60
Table: Registered Pharmaceutical Products by Type, 2002-10 60
Regulatory Developments 60
Intellectual Property Issues 65
Pricing Regime 69
Competitive Landscape 71
Domestic Industry 71
Foreign Industry 74
Table: Table: Multinational Market Activity 75
Table: Leading Malaysian Pharmaceutical And Healthcare Companies 76
Culture-Specific Medicines 76
Pharmaceutical Distribution 78
Table: Drug Wholesalers and Importers, 2002-2010 79
Pharmaceutical Retail Sector 79
Company Profile 82
Chemical Company Of Malaysia 82
Kotra Pharma 85
Novartis 88
Ranbaxy Malaysia 90
Sanofi 92
Demographic Forecast 94
Table: Population Headline Indicators (Malaysia 1990-2025) 95
Table: Key Population Ratios (Malaysia 1990-2025) 95
Table: Urban/Rural Population and Life Expectancy (Malaysia 1990-2025) 96
Table: Population By Age Group (Malaysia 1990-2025) 96
Table: Population By Age Group % (Malaysia 1990-2025) 97
Glossary 99
Methodology 101
Pharmaceutical Expenditure Forecast Model 101
Healthcare Expenditure Forecast Model 101
Notes On Methodology 102
Risk/Reward Index Methodology 103
Index Overview 104
Table: Pharmaceutical Risk/Reward Index Indicators 104
Indicator Weightings 105

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Psoriatic Arthritis Pricing, Reimbursement, and Access

Psoriatic Arthritis Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • June 2016
  • by Datamonitor Healthcare

An absence of head-to-head trials, along with biosimilar launches, provide payers with leverage to demand favorable pricing for branded products in exchange for formulary access. This report addresses ...

Wound Care Market by Product, Surgical, Traditional, Wound Type, Acute, End User, Long-Term Care, Home Healthcare - Global Forecast to 2021

Wound Care Market by Product, Surgical, Traditional, Wound Type, Acute, End User, Long-Term Care, Home Healthcare - Global Forecast to 2021

  • $ 7 150
  • Industry report
  • May 2016
  • by MarketsandMarkets

The wound care market in terms of value is expected to reach USD 20.4 billion by 2021 from USD 17.0 billion in 2016, growing at a CAGR of 3.6% from 2016 to 2021. This market is categorized on the basis ...

MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts

MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts

  • $ 5 995
  • Industry report
  • June 2016
  • by Global Data

MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts Summary Rheumatoid Arthritis (RA) is the commonest autoimmune disease in humans. The disease is prevalent in all ethnic groups, ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.